ESC2017

News

A new sub-analysis of data from a phase 3 trial shows AstraZeneca’s Brilinta cuts the risk of cardiovascular death by 29% in high risk patients.

News

Two top healthcare investors – UK-based GHO and CBC Group of Singapore – have announced a merger to create a massive player in the category.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.